SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Richard Cohen who wrote (1312)10/12/1997 7:44:00 PM
From: contrarian   of 1762
 
Richard,

IMHO, I think IDEC is still a great investment at these prices. If the impact of the new lymphoma treatment is as great as many have stated, then we have event and earnings driven growth ahead. I added to my initial position when IDEC broke into new high ground (low 30's) and last week when profit taking pulled it back to the low 40s. My first position was at around 25.

This stock is definitely a long term buy-accumulate-hold position. I call these investments my "attic" stocks. You put them away and ignore the rapid price swings (unless something funamentally changes of course). Then when everybody knows about it and wants to buy it...you SELL.

Good Luck,

Contrarian
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News